𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enhancing safety and efficacy of RNAi-based gene therapy for the treatment of chronic hepatitis B

✍ Scribed by Michler, T.; Mockenhaupt, S.; Grosse, S.; Grimm, D.; Protzer, U.

Book ID
124120047
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
62 KB
Volume
21
Category
Article
ISSN
1201-9712

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term efficacy and safety of adefovi
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B
✍ Patrick Marcellin; Ting-Tsung Chang; Seng G. Lee Lim; William Sievert; Myron Ton πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 277 KB πŸ‘ 1 views

Treatment of 171 patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) with adefovir dipivoxil (ADV) 10 mg over 48 weeks resulted in significant histological, virological, serological, and biochemical improvement compared with placebo. The long-term efficacy and safety of AD